A maior rede de estudos do Brasil

Grátis
785 pág.
1 4934172924882976788

Pré-visualização | Página 23 de 50

Physiol.,
96:409-418, 2003.
Knoblich, J.A. “Asymmetric cell division during
animal development”. Nat Rev Mol Cell Biol.,
2:11-20, 2001.
Koc, O.N., Gerson, S.L., Cooper, B.W., Dyhouse
SM, Haynesworth, S.E., Caplan, AI and Lazarus
HM. “Rapid hematopoietic recovery after
coinfusion of autologous-blood stem cells and
culture-expanded marrow mesenchymal stem
cells in advanced breast cancer patients
receiving high-dose chemotherapy”. Journal of
Clinical Oncology., 18: 307-316, 2000.
Kondo, M., Scherer, D.C., Miyamoto, T., King,
A.G., Akashi, K., Sugamura, K., Weissman, IL.
“Cell-fate conversion of lymphoid-committed
progenitors by instructive actions of cytokines”.
Nature., 407:383-386, 2000.
Kondo, T., Raff, M. “Oligodendrocyte precursor
cells reprogramme to become multipotent CNS
stem cells”. Science.; 289, 1754-1757, 2000.
Kopen, G.C., Prockop, D.J., Phinney, D.G.
2Marrow stromal cells migrate throughout
forebrain and cerebellum, and they differentiate
into astrocytes after injection into neonatal
mouse brains”. Proc Natl Acad Sci USA.,
96:10711-10716, 1999.
Krause, D.S., Theise, N.D., Collector, M.I.,
Henegariu, O., Hwang, S., Gardner, R., Neutzel,
S., Sharkis, S.J. “Multi-organ, multi-lineage
engraftment by a single bone marrow-derived
stem cell”. Cell.,105:369-377, 2001.
Kuznetsov, S.A., Friedenstein, A.J. and Robey,
P.G. “Factors required for bone marrow
fibroblast colony formation in vitro”. Br J
Haematol., 97: 561-570, 1997.
Lazarus, H.M., Haynesworth S.E., Gerson S.L.,
Rosenthal, N.S. and Caplan, AI. “Ex vivo
expansion and subsequent infusion of human
bone marrow-derived stromal progenitor cells
(mesenchymal progenitor cells): implications for
therapeutic use”. Bone Marrow Transplantation.,
16: 557-564, 1995.
Le Blanc, K., Tammik, C., Rosendahl, K.,
Zetterberg, E., Ringden, O. “HLA expression
and immunologic properties of differentiated
andundifferentiated mesenchymal stem cells”.
Exp Hematol., 31:890-6, 2003.
Magavi, S.S, Leavitt, B.R., Macklis, J.D.
“Induction of neurogenesis in the neocortex of
adult mice”. Nature., 405: 951-955, 2000.
Marty, P.J., Sanberg, P.R., Daugherty, R.M. “Cell
therapy and homeland security: funding
opportunities for biomedical research”. Cell
Transplant.,12: 553-554, 2003.
Miller, J.S., McCullar, V., Punzel, M., Lemischka,
I.R., Moore, K.A. “Single adult human CD34(+)/
Lin-/CD38(-) progenitors give rise to natural
killer cells, B-lineage cells, dendritic cells, and
myeloid cells”. Blood., 93:96-106, 1999.
Minguell, J.J., Erices, A., Conget, P.
“Mesenchymal stem cells”. Exp Biol Med., 226:
507-520, 2001.
Minguell J.J., Conget, P., Erices, A. “Biology and
clinical utilization of mesenchymal progenitor
cells”. Braz J Med Biol Res., 33: 881-887, 2000.
Minguell, J.J., Erices, A. “Células troncales
adultas”. Revista Médica Clínica Las Condes,
13: 123-130, 2002.
Morrison, S.J., Wandycz A.M., Hemmati, H.D.,
Wright DE, Weissman IL. Identification of a lineage
of multipotent hematopoietic progenitors.
Development.,124:1929-1939, 1997.
77
Muller-Sieburg, C.E., Deryugina, E. “The stromal
cells’ guide to the stem cell universe”. Stem
Cells.,13: 477-486, 1995.
Muraca M. “Cell therapy as support or
alternative to liver transplantation”. Transplant
Proc. 35:1047-1048, 2003.
Nuttall, M.E., Patton, A.J., Olivera, D.L., Nadeau,
D.P. and Gowen. M. “Human trabecular bone
cells are able to express both osteoblastic and
adipocytic phenotype: implications for
osteopenic disorders”. J Bone Miner Res., 13:
371-382, 1998.
Olavarria, E., Kanfer, E.J. “Selection and use of
chemotherapy with hematopoietic growth
factors for mobilization of peripheral blood
progenitor cells”. Curr Opin Hematol., 7:191-
196, 2000.
Oshima, H., Rochat, A., Kedzia, C., et al.
“Morphogenesis and renewal of hair follicles
from adult multipotent stem cells”. Cell., 104:
233-245, 2001.
Palis, J., Yoder, MC. “Yolk-sac hematopoiesis:
the first blood cells of mouse and man”. Exp
Hematol., 29: 927-936, 2001.
Papayannopoulou, T. “Hematopoietic stem/
progenitor cell mobilization. A continuing quest
for etiologic mechanisms”. Ann N Y Acad Sci.,
872, 187-197, 1999.
Petersen, B.E., Bowen, W.C., “Patrene KD, et
al. Bone marrow as a potential source of hepatic
oval cells”. Science., 284:1168-1170, 1999.
Pitterger, M.F., Mackay, A.M., Beck, S.C et al.
“Multilineage potential of adult human
mesenchymal stem cells”. Science., 284: 143-
147, 1999.
Prockop, D. “Marrow stromal cells as stem cells
for nonhematopoietic tissues”. Science.,
276:71-74, 1997.
Prockop, D.J. “Further proof of the plasticity of
adult stem cells and their role in tissue
repair”. J Cell Biol.,160: 807-809, 2003.
Punzel, M., Liu, D., Zhang, T., Eckstein, V.,
Miesala, K., Ho, A.D. “The symmetry of initial
divisions of human hematopoietic progenitors
is altered only by the cellular microenvironment”.
Exp Hematol., 31: 339-347, 2003.
Rasmusson, I., Ringden, O., Sundberg, B., Le
Blanc, K. “Mesenchymal stem cells inhibit the
formation of cytotoxic T lymphocytes, butnot
activated cytotoxic T lymphocytes or natural
killer cells”. Transplantation., 76: 1208-13,
2003.
Rosenthat, N. “High hopes for the heart”. N Engl
J Med., 344: 1785-7, 2001.
Scharenberg, C.W., Harkey, M.A., Torok-Storb,
B. “The ABCG2 transporter is an ef ficient
Hoechst 33342 ef flux pump and is
preferentially expressed b immature human
hematopoietic progenitors”. Blood., 99:507-
512, 2002.
Schwarz, E.J., Alexander, G.M., Prockop, D.J.
et al. “Multipotential marrow stromal cells
transduced to produce L-DOPA: engraftment
in a rat model of Parkinson disease”. Hum Gene
Ther., 10: 2539-2549, 1999.
Seale, P., Asakura, A., Rudnicki, M.A. “The
potential of muscle stem cells”. Dev Cell., 1:333-
342, 2001.
Sekiya, I., Larson, B.L., Smith, J.R., Pochampally,
R., Cui, J.G., Prockop, D.J. “Expansion of human
adult stem cells from bone marrow stroma:
conditions that maximize the yields of early
progenitors and evaluate their quality”. Stem
Cells., 20: 530-541, 2002.
Serup, P., Madsen, O.D., Mandrup-Poulsen, T.
“Islet and stem cell transplantation for treating
diabetes”. British Medical J. 322: 29-32, 2001,
Shafritz, D.A. “Rat liver stem cells: Prospects
for the future”. Hepatology., 32: 1399-1400,
2000.
Siminiak, T., Kurpisz, M . “Myocardial
replacement therapy”. Circulation.
2003,108:1167-1171
Simmons, P.J. and Torok-Storb, B. “Identification
of stromal cell precursors in human bone
marrow by a novel monoclonal antibody, STRO-
1”. Blood, 78: 55-62, 1991.
Spradling, A., Drummond-Barbosa, D., Kai, T.
“Stem cells find their niche”. Nature. 2001,
414:98-104.
Starin, A.J., Crosby, H.A. “Hepatic stem cells”.
Gut., 46: 743-745, 2000.
78
Stein, G.S., Lian, J.B. “Molecular mechanisms
mediating proliferation/dif ferentiation
interrelationships during progressive
development of the osteoblast phenotype”.
Endocr Rev., 14:424-442, 1993.
Tavassoli, M., Minguell, J.J. “Homing of
hemopoietic progenitor cells to the marrow”.
Proc Soc Exp Biol Med., 196: 367-373, 1991.
Thorsteinsdottir, U., Sauvageau, G., Humphries,
R.K. “Enhanced in vivo regenerative potential
of HOXB4transduced hematopoietic stem cells
with regulation of their pool size”. Blood.,
94:2605-2612, 1999.
Toma, J.G., Akhavan, M., Fernandez, K.J., et al.
“Isolation of multipotent adult stem cells from
the dermis of mammalian skin”. Nature Cell
Biology., 3:778-784, 2001.
Tropepe, V., Coles, B.L., Chiasson, B.J., et al.
“Retinal stem cells in the adult mammalian eye”.
Science., 287: 2032- 2036, 2000.
Van der Kooy, D., Weiss, S. “Why stem cells”.
Science., 287: 1439-1441, 2000.
Varnum-Finney, B., Xu, L., Brashem-Stein, C.,
Nourigat, C., Flowers, D., Bakkour, S., Pear, W.S.,
“Bernstein ID. Pluripotent, cytokine-dependent,
hematopoietic stem cells are immortalized